Pembrolizumab is one of the most expensive cancer drugs in routine clinical use. For patients considering private treatment, understanding the cost structure - and what is included - is essential before making any commitment. This guide explains the landscape for UK patients.
NHS availability
For many of pembrolizumab's approved indications, NHS access is available through NICE (National Institute for Health and Care Excellence) technology appraisals. Where NICE has issued a positive recommendation, pembrolizumab is funded by the NHS for eligible patients through specialist cancer centres. Patients who meet the eligibility criteria through the NHS route pay nothing for the drug or its administration.
NHS availability, however, is not universal. Some indications are funded only through the Cancer Drugs Fund (CDF), with specific criteria. Access via the NHS requires referral to a specialist oncologist and confirmation of eligibility through the relevant NHS pathway. For patients already under the care of an NHS oncologist, this is the natural first route to explore.
Why some patients consider private treatment
There are several reasons patients look at private pembrolizumab treatment. Some have indications not yet covered by NICE guidance. Some are awaiting NHS approval and wish to start sooner. Others prefer the home-based administration model, which is not routinely available through NHS oncology services. And some simply want the additional oversight and accessibility that a private clinical model can provide.
The cost of private pembrolizumab
The drug itself is the largest component of cost. Pembrolizumab is priced in the region of several thousand pounds per cycle, depending on the dose schedule (200mg every three weeks or 400mg every six weeks). Over a treatment course of up to two years, the cumulative drug cost is substantial.
In addition to the drug, private treatment costs include: clinical assessment and oncologist oversight, nursing administration at each cycle, monitoring blood tests, and any additional clinical consultations. A transparent provider will set out all of these costs clearly before any commitment is made.
What to ask about costs
Before agreeing to private treatment, you should have clear answers to: what is the cost per cycle, what is included in that figure, what additional costs might arise, and what happens to costs if treatment is paused or stopped due to side effects. Any legitimate provider should be willing to give you a clear, written cost breakdown.
We explain costs openly on the Welcome Call - before any financial commitment - because we believe you deserve to understand the full picture before deciding whether to proceed.
Costs are covered transparently on the Welcome Call
Start with the eligibility check. An oncologist reviews it within 24 hours - and the Welcome Call is where we explain costs clearly and answer every question you have.
Check your eligibility